IL17A and cardiomyopathy: The mean of the percentage of CD4+T cells expressing IL-17 in moderate/severe cardiomyopathy patients, Bz-treated patients and healthy individuals were 0.99±0.75, 0.90±0.58 and 0.67±0.57, respectively (Figure 2B).